Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU followed by paclitaxel, trastuzumab and pertuzumab, THP, in the ...
AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) announce positive results from the DESTINY-Breast11 Phase III trial showed Enhertu followed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback